Claritas Rx

Claritas Rx

Delivering actionable information tailored to your unique needs is what sets us apart.

Founded 2011

South San Francisco, United States 103 employees Private Equity Analytics, IT +1

Claritas Rx is a pioneering player in the analytics and information technology space, with a focus on delivering actionable information tailored to the unique needs of their clients. Founded in 2011 and headquartered in the United States, the company has significantly evolved from its origins as a small channel data consultancy. Today, it stands as a leader in patient-level data integration and analytics for the biopharmaceutical industry. The company's growth trajectory and success are further evident from their recent Private Equity Round investment on 09 March 2021, with Questa Capital stepping in as the key investor. This strategic investment not only underscores investor confidence in Claritas Rx but also provides the necessary capital for the company's continued expansion and innovation. Claritas Rx's commitment to improving how biopharmaceutical manufacturers understand their specialty product performance is encapsulated in their slogan, "Delivering actionable information tailored to your unique needs is what sets us apart." Their diverse clientele, ranging from small biotechnology companies to large global manufacturers, highlights the broad impact of their solutions in the industry. As they continue to carve their path as industry leaders, Claritas Rx's tailored approach and analytical prowess position them for sustained success in their niche.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	Undisclosed	1	Questa Capital	09 Mar 2021
Series A	Undisclosed	1	Kiplin Capital	01 Feb 2021
Seed Round	Undisclosed	1	Kiplin Capital	08 Dec 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

Undisclosed

Questa Capital

09 Mar 2021

Series A

Undisclosed

Kiplin Capital

01 Feb 2021

Seed Round

Undisclosed

Kiplin Capital

08 Dec 2017

FAQ About Claritas Rx

Delivering actionable information tailored to your unique needs is what sets us apart.

Claritas Rx was founded in 2011.

Claritas Rx is headquartered in South San Francisco, United States.

Claritas Rx operates in Analytics, IT and Information Technology. Its work centres on biopharmaceutical, data integration, specialty products and patient-level data.

Claritas Rx has approximately 103 employees.

Claritas Rx has completed 3 funding rounds. The latest funding stage is Private Equity.

Top alternatives and competitors to Claritas Rx include Walr, Axonal-Biostatem becomes Heva, Aunalytics, Akar Inti Data, Juice Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Claritas Rx and Walr are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Claritas Rx

Funding Rounds & Investors (3)

Claritas Rx Alternatives & Competitors

FAQ About Claritas Rx